The focus of Berek and Hacker's for four editions has been on the application of basic and clinical science to the clinical practice of gynecologic oncology. That approach has been successful and the book has been well received. The Fifth Edition follows the format of the previous editions, with the addition of color. We will also include a fully searchable companion Website that includes an image bank.
Gynecologic cancer includes cancer of the female lower genital tract: vagina, vulva, cervix, endometrium, uterus, and ovaries. Gynecologic Cancer is the fourth volume in the M.D. Anderson Cancer Care Series, featuring the current standard approach to gynecologic cancer care from the experts at M.D. Anderson Cancer Center. Designed for the practicing oncologist, this clinical guidebook allows for quick, authoritative access to the latest and best multimodality therapies. Topics covered in this volume include primary prevention and early detection, preinvasive diseases of female lower genital tract, pathology and imaging of gynecologica malignancies, treatment of vaginal, cervical, endometrial, uterine cancers. Discussions also address fertility-sparing options for treatment of women with gynecologica cancers as well as sexuality in women with gyn malignancies. Each of the 20 chapters ends with an up-to-date list of suggested readings, as well as "key practice points" highlighting the most principles and practices of each chapter for at-a-glance reference. More than 80 illustrations complement the text. This thorough, practical volume is the essential clinical guide for the oncologists, surgeons, and all physicians involved in the care of patients with gynecologic cancer.
This book was written for the complex scenario of fertility-sparing management in gynaecological cancer. In reproductive age women, appropriate counselling is mandatory in any cancer diagnosis, including discussing the long-term consequences of the different treatment options on fertility and the possibility of fertility preservation. However, women affected by gynaecological cancer must consider that treatment options including hysterectomy and bilateral oophorectomy in most cases. Therefore, in gynaecological cancer, the standard treatment often consists of an inevitable loss of fertility. The direct consequence is that fertility preservation management does not always result in the optimal treatment of the disease, which increases the risk of worsening oncologic outcomes. This book discusses all the elements involved in managing these patients to provide a complete and detailed overview of fertility preservation management options in young women affected by gynaecological cancers. Specifically, this book discusses the role of genetic assessment and counselling, the effect of anticancer treatments for gynaecological cancer on fertility, classic fertility preservation techniques adapted to gynaecological cancer, detailed and specific fertility preservation management for cervical, ovarian, and endometrial cancer, and the role of a multidisciplinary approach in these patients.
In an era of promising advances in cancer research, there are considerable and even alarming gaps in the fundamental knowledge and understanding of ovarian cancer. Researchers now know that ovarian cancer is not a single disease-several distinct subtypes exist with different origins, risk factors, genetic mutations, biological behaviors, and prognoses. However, persistent questions have impeded progress toward improving the prevention, early detection, treatment, and management of ovarian cancers. Failure to significantly improve morbidity and mortality during the past several decades is likely due to several factors, including the lack of research being performed by specific disease subtype, lack of definitive knowledge of the cell of origin and disease progression, and incomplete understanding of genetic and non-genetic risk factors. Ovarian Cancers examines the state of the science in ovarian cancer research, identifies key gaps in the evidence base and the challenges to addressing those gaps, considers opportunities for advancing ovarian cancer research, and examines avenues for translation and dissemination of new findings and communication of new information to patients and others. This study makes recommendations for public- and private-sector efforts that could facilitate progress in reducing the incidence of morbidity and mortality from ovarian cancers.
With an emphasis on a practical, "how-to" approach, this comprehensive text addresses the most important and commonly performed procedures in gynecologic oncology surgery today. Written by leaders in the field, Principles of Gynecologic Oncology Surgery clearly describes the critical steps for each procedure, provides up-to-date information on the recent literature, and includes high-quality illustrations of anatomy and technique. - Covers hot topics such as Enhanced Recovery After Surgery (ERAS), sentinel lymph node mapping, and minimally invasive surgery (robotic surgery, advanced laparoscopic surgery, and single site surgery). - Includes expert coverage of reconstructive surgery, colorectal surgery, urology, and vascular surgery, each written by surgeon leaders in that particular field. - Addresses the diagnosis, management and prevention of surgical complications.
This comprehensive volume provides exhaustive interpretations of surgery for gynecologic cancer. In these chapters, expert authors expound the history, principles and indications, preoperative evaluations, techniques, morbidity, and the future prospects for each surgical procedure. Also included are comparisons of the training systems of gynecologic surgeons in Japan and the USA. Recently, minimally invasive surgeries such as laparoscopic and robotic approaches have been introduced into the gynecologic oncology field. Readers will be interested to know the history, advances, and current status of gynecologic surgery in Japan. This collection methodically broadens understanding of new surgical methods with quality assurance aimed at saving the cancer patient's life, from the point of view of gynecologic oncologists. Thus the book benefits not only experienced gynecologists, but also young physicians and all medical oncologists who are involved in gynecologic cancers.
Integrative Sexual Health explores beyond the standard topics in men's and women's health, drawing on a diverse research literature to provide an overview of sexual biology and sexual dysfunction, diverse lifespan, lifestyle and environmental impacts on sexual function, integrative medicine solutions to sexual problems, and traditional eastern and western treatment approaches to healing sexual difficulties. This comprehensive guide written by experts in the field provides clinical vignettes, detailed treatment strategies for mitigating the side effects of both medications and sexual dysfunction associated with medical illness and poor lifestyle habits, and extensive further reading resources. Integrative treatment modalities not typically consulted in mainstream medicine, such as traditional Chinese medicine, Ayurvedic medicine, aromatherapy, and botanical medicine, are presented with the best evidence, in a clinically relevant manner. Part of the Weil Integrative Medicine Library, this volume is a must read for the specialist and non-specialist alike who wish to address sexual problems using an integrative medicine approach, and acquire tools to maintain lifetime optimal health and vitality that supports healthy sexuality. Integrative medicine is defined as healing-oriented medicine that takes account of the whole person (body, mind, and spirit) as well as all aspects of lifestyle; it emphasizes the therapeutic relationship and makes use of appropriate therapies, both conventional and alternative. Series editor Andrew Weil, MD, is Professor and Director of the Arizona Center for Integrative Medicine at the University of Arizona. Dr. Weil's program was the first such academic program in the U.S., and its stated goal is "to combine the best ideas and practices of conventional and alternative medicine into cost effective treatments without embracing alternative practices uncritically."
****When not purchasing directly from the official sales agents of the WHO, especially at online bookshops, please note that there have been issues with counterfeited copies. Buy only from known sellers and if there are quality issues, please contact the seller for a refund.***** Female Genital Tumours is the fourth volume in the 5th edition of the WHO series on the classification of human tumours. This series (also known as the WHO Blue Books) is regarded as the gold standard for the diagnosis of tumours and comprises a unique synthesis of histopathological diagnosis with digital and molecular pathology. These authoritative and concise reference books provide indispensable international standards for anyone involved in the care of patients with cancer or in cancer research, underpinning individual patient treatment as well as research into all aspects of cancer causation, prevention, therapy, and education. What's new in this edition? The 5th edition, guided by the WHO Classification of Tumours Editorial Board, will establish a single coherent cancer classification presented across a collection of individual volumes organized on the basis of anatomical site (digestive system, breast, soft tissue and bone, etc.) and structured in a systematic manner, with each tumour type listed within a taxonomic classification: site, category, family (class), type, and subtype. In each volume, the entities are now listed from benign to malignant and are described under an updated set of headings, including histopathology, diagnostic molecular pathology, staging, and easy-to-read essential and desirable diagnostic criteria. Who should read this book? - Pathologists - Oncologists - Cancer researchers - Surgeons - Epidemiologists - Cancer registrars This volume - Prepared by 191 authors and editors - Contributors from around the world - More than 850 high-quality images - More than 3100 references
PROLOG is a voluntary, strictly confidential, personal continuing education resource that is designed to be stimulating and enjoyable. By participating in PROLOG, obstetrician-gynecologists will be able to do the following: - Review and update clinical knowledge - Recognize areas of knowledge and practice in which they excel, be stimulated to explore other areas of the specialty, and identify areas requiring further study - Plan continuing education activities in light of identified strengths and deficiencies - Compare and relate present knowledge and skills with those of other participants - Obtain continuing medical education credit, if desired - Have complete personal control of the setting and of the pace of the experience The obstetrician-gynecologist who completes Gynecologic Oncology and Critical Care, Eighth Edition, will be able to - identify epidemiologic factors that contribute to the risks of various malignancies and determine appropriate screening tests. - analyze the pathophysiology and evaluate the histopathology of various malignancies. - associate symptoms with early onset of specific malignancies, determine appropriate diagnostic tests, and select diagnosis. -
America's Health Care Safety Net explains how competition and cost issues in today's health care marketplace are posing major challenges to continued access to care for America's poor and uninsured. At a time when policymakers and providers are urgently seeking guidance, the committee recommends concrete strategies for maintaining the viability of the safety netâ€"with innovative approaches to building public attention, developing better tools for tracking the problem, and designing effective interventions. This book examines the health care safety net from the perspectives of key providers and the populations they serve, including: Components of the safety netâ€"public hospitals, community clinics, local health departments, and federal and state programs. Mounting pressures on the systemâ€"rising numbers of uninsured patients, decline in Medicaid eligibility due to welfare reform, increasing health care access barriers for minority and immigrant populations, and more. Specific consequences for providers and their patients from the competitive, managed care environmentâ€"detailing the evolution and impact of Medicaid managed care. Key issues highlighted in four populationsâ€"children with special needs, people with serious mental illness, people with HIV/AIDS, and the homeless.
